跳至主要内容
临床试验/NL-OMON50427
NL-OMON50427已完成4 期

Topical Ingenol mebutate versus 5% 5-fluorouracil versus 5% Imiquimod versus photodynamic therapy in treatment of actinic keratosis: a multi-center randomized efficacy and cost-effectiveness study - IM vs 5% 5-FU vs 5% IMI vs PDT in treatment of AK

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 624 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
624

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patients older than 18 years
  • - Female in child bearing potential should be using contraceptive
  • measures, during and till 3
  • months post-treatment
  • - Fitzpatrick skintype I-IV
  • - Clinically confirmed diagnosis of AK
  • - One joint area of minimal 25 cm2 and maximal 100 cm2 of AK
  • - Minimum of 5 AK lesions within the joint area
  • - AK Olsen grade I-III
  • - Location: head/neck area

排除标准

  • - Received any kind of treatment for AK in the past 3 months, except for
  • cryosurgery outside the treatment area.
  • - (N)MSC in target area
  • - Immuno-comprised status
  • - Use of immunosuppressant drugs in the past 3 months and / or at time of
  • treatment (inhalation corticosteroids / nasal corticosteroids are permitted)
  • - Porphyria
  • - Not able to give informed consent
  • - Allergy to study drugs or peanut/nut/soy products
  • - Pregnant and breastfeeding women
  • - Genetic skin cancer disorders
  • - No understanding of dutch language

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验